Pancreatic Cancer Growth Promoting Protein Unveiled

A protein that plays an important role in pancreatic cancer growth has been identified by the researchers at Stanford University School of Medicine.

Researchers at Stanford University School of Medicine have identified a protein that plays an important role in pancreatic cancer growth.

In a study on mice, they found that blocking the expression of the protein connective tissue growth factor (CTGF), also known as CCN2, slowed or prevented tumour growth and made cultured cancer cells vulnerable to the conditions of low oxygen that occur in solid tumours.

Pancreatic Cancer - All About the Disease, its Diagnosis and Management
Pancreatic cancer often involves its exocrine part. It grows aggressively, and often detected late. Treatment options include surgery, radiation and chemotherapy.

"This research clearly shows that inhibiting the protein inhibits the tumour's ability to grow," said cancer biologist Amato Giaccia, PhD.

"Ultimately, we'd like to be able to specifically knock out the expression of this protein in pancreatic tumours in humans," he added.

The researchers have revealed that CCN2 is involved in the abnormal growth of connective tissue in response to injury or disease.

DNA Repair Gene Polymorphism, A Marker For Pancreatic Cancer
Nine different polymorphism in DNA repair gene associated with pancreatic cancer risk has been identified by the researchers from the University of Texas

It was also thought to be involved in pancreatic tumour progression, although the exact role it played was unknown.

Giaccia and his collaborators found that human pancreatic cancer cells expressing high levels of CCN2 grew robustly when injected under the skin of mice.

Quiz on Pancreas
Pancreas is both an endocrine and an exocrine organ. It secretes insulin, which is required for sugar breakdown. To learn more about the unique functions of the pancreas, engage in the following quiz.

On the other hand, pancreatic cancer cells in which CCN2 expression was suppressed were either less likely, or unable, to form tumours when injected into mice.

They also found that blocking CCN2 expression in cultured pancreatic cancer cells made them significantly more sensitive to hypoxia-induced death than their peers.

New Hope for Pancreatic Cancer Patients Via Chemoprevention Gene Therapy
A new chemoprevention gene therapy (CGT) may be effective in preventing and treating pancreatic cancer, according to a new study.

Moreover, CCN2 was more highly expressed in pancreatic tumour samples from human patients than in neighbouring tissue, and CCN2 expression seemed to correlate with the expression of another protein expressed by hypoxic cells.

"We saw a pronounced effect of CCN2 inhibition in these experiments in mice," said Giaccia.

"Our hope is that one day a combination of standard therapy and antibody treatment will have an effect on tumour progression in human patients," he added.

The study has been published in the journal Cancer Research.

Source-ANI
PRI/SK